June 12, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: This week in Drug Discovery (19 – 23 January) 
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > This week in Drug Discovery (19 – 23 January) 
Drug development

This week in Drug Discovery (19 – 23 January) 

By Newsroom
Last updated: January 25, 2026
1 Min Read
Share


News round-up for 19 – 23 January by Bruno Quinney, Content Team at DDW. 

This week in DDW, innovative therapies have shown encouraging results in tackling melanoma and concussion. Elsewhere, a UK-Canadian partnership looks to advance vaccine technology. 

The top stories: 

 

Combination therapy could slash melanoma mortality risk 

An investigational mRNA-based individualised neoantigen therapy (INT) reduced the risk of high-risk melanoma recurrence or death by 49% when combined…



Source link

TAGGED:CanadaCell and gene therapyClinical trialConcussionELRIGEuropean Medicines AgencyMelanomaMerckModernaOxeia BiopharmaceuticalsregulatoryUKVaccines
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Nestlé sold treated water as ‘natural’ in alleged marketing fraud

Environmental Science
May 23, 2025

20 ChatGPT Prompts That Rewire How You Think and Act ($21…

Learn 20 ChatGPT prompts for personal development including life planning, habit design, mental clarity, discipline…

June 11, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Early studies identify a new treatment for E coli infections

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E coli…

Drug development
April 5, 2025

Arena Clinical Data Management | Certara

The Pinnacle 21 Enterprise platform is designed to transform and accelerate the clinical data lifecycle with precision and efficiency. Powered…

Drug development
July 11, 2025

NutraONE and Nutrifactor Laboratories form exclusive distribution partnership to expand across five key international markets

Dubai, UAE, — (ARAB NEWSWIRE) — NutraONE, a wellness distribution company, has announced an exclusive distribution partnership with Nutrifactor Laboratories,…

Business
February 11, 2026

Mechanistic Modeling Meets Challenges in ADC Development

Antibody-drug conjugates, or ADCs, are monoclonal antibodies that are linked to another drug (“payload”) via a molecular linker. This technology…

Drug development
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

20 ChatGPT Prompts That Rewire How You Think and Act ($21…
June 11, 2026
The GPT-5.5 Release Explained: What Changed and How to Use It…
June 11, 2026
The Front-End Shift
June 11, 2026
Practical Considerations for Your Sub-Contracted Process…
June 11, 2026

Life Science Magazines

20 ChatGPT Prompts That Rewire How You Think and Act ($21…
June 11, 2026
The GPT-5.5 Release Explained: What Changed and How to Use It…
June 11, 2026
The Front-End Shift
June 11, 2026
Practical Considerations for Your Sub-Contracted Process…
June 11, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?